CAYMAN CHEMICAL COMPANY Non-Antibody Products — page 196 of 644
Non-Antibody Products
Page 196 of 644
| Name | Description | Size | Catalog # | |
|---|---|---|---|---|
| DL-threo-PDMP (hydrochloride) | An inhibitor of sphingolipid biosynthesis; inhibits glucosylceramide synth… | 10 mg | 10005276-10 | More Info |
| DL-threo-PDMP (hydrochloride) | An inhibitor of sphingolipid biosynthesis; inhibits glucosylceramide synth… | 100 mg | 10005276-100 | More Info |
| DL-threo-PDMP (hydrochloride) | An inhibitor of sphingolipid biosynthesis; inhibits glucosylceramide synth… | 50 mg | 10005276-50 | More Info |
| DL-threo-PPMP (hydrochloride) | An inhibitor of glucosylceramide synthase; inhibits glucosylceramide synth… | 100 mg | 17236-100 | More Info |
| DL-threo-PPMP (hydrochloride) | An inhibitor of glucosylceramide synthase; inhibits glucosylceramide synth… | 25 mg | 17236-25 | More Info |
| DL-threo-PPMP (hydrochloride) | An inhibitor of glucosylceramide synthase; inhibits glucosylceramide synth… | 5 mg | 17236-5 | More Info |
| DL-threo-PPMP (hydrochloride) | An inhibitor of glucosylceramide synthase; inhibits glucosylceramide synth… | 50 mg | 17236-50 | More Info |
| DL-Tryptophan | A racemic mixture of D- and L-tryptophan; serum levels are negatively corr… | 100 g | 31210-100 | More Info |
| DL-Tryptophan | A racemic mixture of D- and L-tryptophan; serum levels are negatively corr… | 25 g | 31210-25 | More Info |
| DL-Tryptophan | A racemic mixture of D- and L-tryptophan; serum levels are negatively corr… | 50 g | 31210-50 | More Info |
| DL-Tyrosine | A racemic mixture of D- and L-tyrosine | 100 g | 36460-100 | More Info |
| DL-Tyrosine | A racemic mixture of D- and L-tyrosine | 25 g | 36460-25 | More Info |
| DL-Tyrosine | A racemic mixture of D- and L-tyrosine | 250 g | 36460-250 | More Info |
| DL-Tyrosine | A racemic mixture of D- and L-tyrosine | 50 g | 36460-50 | More Info |
| D-Luciferin | A chemiluminescent substrate of firefly luciferase which produces light up… | 10 mg | 25836-10 | More Info |
| D-Luciferin | A chemiluminescent substrate of firefly luciferase which produces light up… | 100 mg | 25836-100 | More Info |
| D-Luciferin | A chemiluminescent substrate of firefly luciferase which produces light up… | 250 mg | 25836-250 | More Info |
| D-Luciferin | A chemiluminescent substrate of firefly luciferase which produces light up… | 50 mg | 25836-50 | More Info |
| D-Luciferin (potassium salt) | A chemiluminescent substrate of firefly luciferase which produces light up… | 1 g | 14681-1 | More Info |
| D-Luciferin (potassium salt) | A chemiluminescent substrate of firefly luciferase which produces light up… | 100 mg | 14681-100 | More Info |
| D-Luciferin (potassium salt) | A chemiluminescent substrate of firefly luciferase which produces light up… | 50 mg | 14681-50 | More Info |
| D-Luciferin (potassium salt) | A chemiluminescent substrate of firefly luciferase which produces light up… | 500 mg | 14681-500 | More Info |
| D-Luciferin (sodium salt) | A chemiluminescent substrate of firefly luciferase which produces light up… | 1 g | 14682-1 | More Info |
| D-Luciferin (sodium salt) | A chemiluminescent substrate of firefly luciferase which produces light up… | 100 mg | 14682-100 | More Info |
| D-Luciferin (sodium salt) | A chemiluminescent substrate of firefly luciferase which produces light up… | 50 mg | 14682-50 | More Info |
| D-Luciferin (sodium salt) | A chemiluminescent substrate of firefly luciferase which produces light up… | 500 mg | 14682-500 | More Info |
| [D-Lys3]-GHRP-6 (trifluoroacetate salt) | An antagonist of GHS-R1a (Ki = 4.25 nM); inhibits ghrelin-induced cAMP acc… | 10 mg | 36862-10 | More Info |
| [D-Lys3]-GHRP-6 (trifluoroacetate salt) | An antagonist of GHS-R1a (Ki = 4.25 nM); inhibits ghrelin-induced cAMP acc… | 25 mg | 36862-25 | More Info |
| [D-Lys3]-GHRP-6 (trifluoroacetate salt) | An antagonist of GHS-R1a (Ki = 4.25 nM); inhibits ghrelin-induced cAMP acc… | 5 mg | 36862-5 | More Info |
| [D-Lys3]-GHRP-6 (trifluoroacetate salt) | An antagonist of GHS-R1a (Ki = 4.25 nM); inhibits ghrelin-induced cAMP acc… | 50 mg | 36862-50 | More Info |
| D-Lysine lactam | A chiral building block; has been used in the synthesis of a chiral synthe… | 100 mg | 31684-100 | More Info |
| D-Lysine lactam | A chiral building block; has been used in the synthesis of a chiral synthe… | 250 mg | 31684-250 | More Info |
| D-Lysine lactam | A chiral building block; has been used in the synthesis of a chiral synthe… | 50 mg | 31684-50 | More Info |
| D-Lysine lactam | A chiral building block; has been used in the synthesis of a chiral synthe… | 500 mg | 31684-500 | More Info |
| DMABA-d10 NHS ester | DMABA-d10 NHS ester is intended for use in combination with DMABA NHS este… | 1 mg | 11219-1 | More Info |
| DMABA-d10 NHS ester | DMABA-d10 NHS ester is intended for use in combination with DMABA NHS este… | 10 mg | 11219-10 | More Info |
| DMABA-d10 NHS ester | DMABA-d10 NHS ester is intended for use in combination with DMABA NHS este… | 5 mg | 11219-5 | More Info |
| DMABA-d4 NHS ester | DMABA-d4 NHS ester is intended for use in combination with DMABA NHS ester… | 1 mg | 11217-1 | More Info |
| DMABA-d4 NHS ester | DMABA-d4 NHS ester is intended for use in combination with DMABA NHS ester… | 10 mg | 11217-10 | More Info |
| DMABA-d4 NHS ester | DMABA-d4 NHS ester is intended for use in combination with DMABA NHS ester… | 25 mg | 11217-25 | More Info |
| DMABA-d4 NHS ester | DMABA-d4 NHS ester is intended for use in combination with DMABA NHS ester… | 5 mg | 11217-5 | More Info |
| DMABA-d6 NHS ester | DMABA-d6 NHS ester is intended for use in combination with DMABA NHS ester… | 1 mg | 11218-1 | More Info |
| DMABA-d6 NHS ester | DMABA-d6 NHS ester is intended for use in combination with DMABA NHS ester… | 10 mg | 11218-10 | More Info |
| DMABA-d6 NHS ester | DMABA-d6 NHS ester is intended for use in combination with DMABA NHS ester… | 5 mg | 11218-5 | More Info |
| DMABA NHS ester | A reagent that reacts with the primary amine group of PE lipids; facilitat… | 100 mg | 11216-100 | More Info |
| DMABA NHS ester | A reagent that reacts with the primary amine group of PE lipids; facilitat… | 50 mg | 11216-50 | More Info |
| DMABA NHS ester | A reagent that reacts with the primary amine group of PE lipids; facilitat… | 500 mg | 11216-500 | More Info |
| 17-DMAG | A water-soluble derivative of geldanamycin which potently inhibits Hsp90 (… | 1 mg | 11036-1 | More Info |
| 17-DMAG | A water-soluble derivative of geldanamycin which potently inhibits Hsp90 (… | 10 mg | 11036-10 | More Info |
| 17-DMAG | A water-soluble derivative of geldanamycin which potently inhibits Hsp90 (… | 5 mg | 11036-5 | More Info |
| 2,4-DMA (hydrochloride) | An amphetamine that acts as a serotonin 5-HT2 receptor agonist (apparent p… | 1 mg | 19746-1 | More Info |
| 2,4-DMA (hydrochloride) | An amphetamine that acts as a serotonin 5-HT2 receptor agonist (apparent p… | 5 mg | 19746-5 | More Info |
| 2,5-DMA (hydrochloride) | An analytical reference standard categorized as an amphetamine; regulated… | 1 mg | 34991-1 | More Info |
| 2,5-DMA (hydrochloride) | An analytical reference standard categorized as an amphetamine; regulated… | 5 mg | 34991-5 | More Info |
| 2,6-DMA (hydrochloride) | An amphetamine that acts as a serotonin 5-HT2 receptor agonist (apparent p… | 1 mg | 19745-1 | More Info |
| 2,6-DMA (hydrochloride) | An amphetamine that acts as a serotonin 5-HT2 receptor agonist (apparent p… | 5 mg | 19745-5 | More Info |
| 3,4-DMA (hydrochloride) | An amphetamine whose physiological and toxicological properties are not kn… | 1 mg | 14142-1 | More Info |
| 3,4-DMA (hydrochloride) | An amphetamine whose physiological and toxicological properties are not kn… | 5 mg | 14142-5 | More Info |
| 3,5-DMA (hydrochloride) | An amphetamine whose physiological and toxicological properties are not kn… | 1 mg | 19743-1 | More Info |
| 3,5-DMA (hydrochloride) | An amphetamine whose physiological and toxicological properties are not kn… | 5 mg | 19743-5 | More Info |
| DMA (hydrochloride) | A radi; oprotective agent; decreases radiation-induced lethality without a… | 1 mg | 30416-1 | More Info |
| DMA (hydrochloride) | A radi; oprotective agent; decreases radiation-induced lethality without a… | 10 mg | 30416-10 | More Info |
| DMA (hydrochloride) | A radi; oprotective agent; decreases radiation-induced lethality without a… | 5 mg | 30416-5 | More Info |
| 2,5-DMA (hydrochloride) (exempt preparation) | An analytical reference standard categorized as an amphetamine; provided a… | 1 mg | 38144-1 | More Info |
| 3,4-DMA-NBOMe (hydrochloride) | An amphetamine / phenethylamine hybrid whose physiological and toxicologic… | 1 mg | 18753-1 | More Info |
| 3,4-DMA-NBOMe (hydrochloride) | An amphetamine / phenethylamine hybrid whose physiological and toxicologic… | 5 mg | 18753-5 | More Info |
| D-Mannitol | An analytical reference standard categorized as an alcohol sugar that is u… | 25 mg | 23372-25 | More Info |
| D-Mannoheptulose | A heptose that inhibits glucokinases and hexokinases from diverse organism… | 10 mg | 16548-10 | More Info |
| D-Mannoheptulose | A heptose that inhibits glucokinases and hexokinases from diverse organism… | 25 mg | 16548-25 | More Info |
| D-Mannoheptulose | A heptose that inhibits glucokinases and hexokinases from diverse organism… | 5 mg | 16548-5 | More Info |
| D-Mannoheptulose | A heptose that inhibits glucokinases and hexokinases from diverse organism… | 50 mg | 16548-50 | More Info |
| D-Mannosamine (hydrochloride) | An amino monosaccharide; has been found as a component of LPS isolated fro… | 1 g | 36231-1 | More Info |
| D-Mannosamine (hydrochloride) | An amino monosaccharide; has been found as a component of LPS isolated fro… | 10 g | 36231-10 | More Info |
| D-Mannosamine (hydrochloride) | An amino monosaccharide; has been found as a component of LPS isolated fro… | 5 g | 36231-5 | More Info |
| D-Mannosamine (hydrochloride) | An amino monosaccharide; has been found as a component of LPS isolated fro… | 500 mg | 36231-500 | More Info |
| D-Mannose | An aldohexose monosaccharide; an epimer of glucose; decreases T cell proli… | 100 g | 27388-100 | More Info |
| D-Mannose | An aldohexose monosaccharide; an epimer of glucose; decreases T cell proli… | 250 g | 27388-250 | More Info |
| D-Mannose | An aldohexose monosaccharide; an epimer of glucose; decreases T cell proli… | 500 g | 27388-500 | More Info |
| D-Mannose-6-Phosphate (sodium salt hydrate) | A phosphorylated aldohexose that can be used to produce glucose, mannitol,… | 10 mg | 18890-10 | More Info |
| D-Mannose-6-Phosphate (sodium salt hydrate) | A phosphorylated aldohexose that can be used to produce glucose, mannitol,… | 100 mg | 18890-100 | More Info |
| D-Mannose-6-Phosphate (sodium salt hydrate) | A phosphorylated aldohexose that can be used to produce glucose, mannitol,… | 50 mg | 18890-50 | More Info |
| D-Mannose-6-Phosphate (sodium salt hydrate) | A phosphorylated aldohexose that can be used to produce glucose, mannitol,… | 500 mg | 18890-500 | More Info |
| DMAPP (ammonium salt) | Dimethylallyl pyrophosphate and isopentyl pyrophosphate undergo condensati… | 1 mg | 63180-1 | More Info |
| DMAPP (ammonium salt) | Dimethylallyl pyrophosphate and isopentyl pyrophosphate undergo condensati… | 10 mg | 63180-10 | More Info |
| DMAPP (ammonium salt) | Dimethylallyl pyrophosphate and isopentyl pyrophosphate undergo condensati… | 5 mg | 63180-5 | More Info |
| DMAPP (ammonium salt) | Dimethylallyl pyrophosphate and isopentyl pyrophosphate undergo condensati… | 500 µg | 63180-500 | More Info |
| DMAT | A cell-permeable inhibitor of CK2 (IC50 = 0.13 µM); also inhibits Pi… | 1 mg | 21182-1 | More Info |
| DMAT | A cell-permeable inhibitor of CK2 (IC50 = 0.13 µM); also inhibits Pi… | 10 mg | 21182-10 | More Info |
| DMAT | A cell-permeable inhibitor of CK2 (IC50 = 0.13 µM); also inhibits Pi… | 25 mg | 21182-25 | More Info |
| DMAT | A cell-permeable inhibitor of CK2 (IC50 = 0.13 µM); also inhibits Pi… | 5 mg | 21182-5 | More Info |
| DMG-PEG(2000) | A lipid excipient; administration of FAH mRNA in DMG-PEG(2000)-containing… | 1 g | 33945-1 | More Info |
| DMG-PEG(2000) | A lipid excipient; administration of FAH mRNA in DMG-PEG(2000)-containing… | 500 mg | 33945-500 | More Info |
| DMH1 | A potent inhibitor of the kinase activity of ALK2 (IC50 = 13-108 nM); disr… | 1 mg | 16679-1 | More Info |
| DMH1 | A potent inhibitor of the kinase activity of ALK2 (IC50 = 13-108 nM); disr… | 10 mg | 16679-10 | More Info |
| DMH1 | A potent inhibitor of the kinase activity of ALK2 (IC50 = 13-108 nM); disr… | 5 mg | 16679-5 | More Info |
| DMH1 | A potent inhibitor of the kinase activity of ALK2 (IC50 = 13-108 nM); disr… | 50 mg | 16679-50 | More Info |
| DMH4 | A VEGFR2 inhibitor (IC50 = 0.16 µM in a cell-free assay); selectivel… | 1 mg | 27653-1 | More Info |
| DMH4 | A VEGFR2 inhibitor (IC50 = 0.16 µM in a cell-free assay); selectivel… | 10 mg | 27653-10 | More Info |
| DMH4 | A VEGFR2 inhibitor (IC50 = 0.16 µM in a cell-free assay); selectivel… | 25 mg | 27653-25 | More Info |
| DMH4 | A VEGFR2 inhibitor (IC50 = 0.16 µM in a cell-free assay); selectivel… | 5 mg | 27653-5 | More Info |
CAYMAN CHEMICAL COMPANY
CAYMAN CHEMICAL COMPANY
1180 East Ellsworth Road
Ann Arbor MI 48108
P: (734) 971-3335
P: (800) 364-9897 (USA & Canada only)
F: (734) 971-3640
Customer Service: custserv@caymanchem.com
Technical Support: techserv@caymanchem.com
Sales: sales@caymanchem.com
http://www.caymanchem.com
Return to Profile